Back to Stakeholders
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchUniversities and Colleges with Dedicated Psychedelic Research Groups
Research, Drug Development & Manufacturing

University of Manchester

United Kingdom
1 Trial

Clerkenwell Health is collaborating with researchers at the University of Manchester to run Phase II studies. Trials here aim to assess the impact of talking therapy informed by Perceptual Control Theory alongside different doses of psilocybin, led by Dr Sara Tai who has previously been involved with Compass Pathways.

Academic Research

0 papers

Published Papers

0

Trial Involvement

1

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
academic
HQ
United Kingdom
Website
Visit

Collaborated Trials

1
CompletedI

Study Where Pharmaco Magnetic Resonance Imaging (MRI) Effects of AZD6765 Will be Compared to Placebo in Depressive Male and Female Subjects

Start Date
Compounds
Placebo, Ketamine